Protocol for an evaluation of the initiation of an integrated longitudinal outpatient care model for severe chronic non-communicable diseases (PEN-Plus) at secondary care facilities (district hospitals) in 10 lower-income countries

Author:

Adler Alma JORCID,Wroe Emily B,Atzori Andrea,Bay Neusa,Bekele Wondu,Bhambhani Victoria M,Nkwiro Remy Bitwayiki,Boudreaux ChantelleORCID,Calixte Dawson,Chiwanda Banda JonathanORCID,Coates Matthew M,Dagnaw Wubaye Walelgne,Domingues Katia,Drown Laura,Dusabeyezu Symaque,Fenelon Darius,Gupta Neil,Ssinabulya Isaac,Jain Yogesh,Kalkonde YogeshwarORCID,Kamali Innocent,Karekezi Catherine,Karmacharya Biraj Man,Koirala BhagawanORCID,Makani Julie,Manenti Fabio,Mangwiro Alexio,Manuel Beatriz,Masiye Jones K,Goma Fastone Mathew,Mayige Mary Theodory,McLaughlin Amy,Mensah Emmanuel,Salipa Nicole Mocumbi,Mutagaywa ReubenORCID,Mutengerere Alvern,Ngoga Gedeon,Patiño Marta,Putoto Giovanni,Ruderman Todd,Salvi Devashri,Sesay SantigieORCID,Taero Fameti,Tostão Emílio,Toussaint Sterman,Bukhman Gene,Mocumbi Ana Olga

Abstract

IntroductionThe Package of Essential Noncommunicable Disease Interventions—Plus (PEN-Plus) is a strategy decentralising care for severe non-communicable diseases (NCDs) including type 1 diabetes, rheumatic heart disease and sickle cell disease, to increase access to care. In the PEN-Plus model, mid-level clinicians in intermediary facilities in low and lower middle income countries are trained to provide integrated care for conditions where services traditionally were only available at tertiary referral facilities. For the upcoming phase of activities, 18 first-level hospitals in 9 countries and 1 state in India were selected for PEN-Plus expansion and will treat a variety of severe NCDs. Over 3 years, the countries and state are expected to: (1) establish PEN-Plus clinics in one or two district hospitals, (2) support these clinics to mature into training sites in preparation for national or state-level scale-up, and (3) work with the national or state-level stakeholders to describe, measure and advocate for PEN-Plus to support development of a national operational plan for scale-up.Methods and analysisGuided by Proctor outcomes for implementation research, we are conducting a mixed-method evaluation consisting of 10 components to understand outcomes in clinical implementation, training and policy development. Data will be collected through a mix of quantitative surveys, routine reporting, routine clinical data and qualitative interviews.Ethics and disseminationThis protocol has been considered exempt or covered by central and local institutional review boards. Findings will be disseminated throughout the project’s course, including through quarterly M&E discussions, semiannual formative assessments, dashboard mapping of progress, quarterly newsletters, regular feedback loops with national stakeholders and publication in peer-reviewed journals.

Funder

The Leona M. and Harry B. Helmsley Charitable Trust

Publisher

BMJ

Reference21 articles.

1. Bukhman G , Kidder A , eds. The Partners In Health guide to chronic care integration for endemic non-communicable diseases. Rwanda edition. Cardiac, renal, diabetes, pulmonary, and palliative care. Boston, MA: Partners In Health, 2011.

2. The PEN-plus partnership: addressing severe chronic non-communicable diseases among the poorest billion;Bukhman;Lancet Diabetes Endocrinol,2023

3. World Health Organization Regional Office for Africa . Report on regional consultation: WHO PEN and integrated outpatient care for severe, chronic NCDS at first referral hospitals in the African region (PEN-plus). 2019. Available: https://www.afro.who.int/sites/default/files/2020-01/PENPEN-Plus%20Meeting%20Report%20-%20WHO%20AFRO%20Rwanda%20July%202019%20w%20updated%20Photos.pdf

4. Cost of integrated chronic care for severe non-communicable diseases at district hospitals in rural Rwanda;Eberly;BMJ Glob Health,2019

5. Implementation outcomes of national decentralization of integrated outpatient services for severe non‐communicable diseases to district hospitals in Rwanda

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3